Disease progression in a cohort of infants with vertically acquired HIV infection observed from birth: The Women and Infants Transmission Study (WITS)

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 18, Issue 3, 1998, Pages 221-228

  Diaz, Clemente ^a,k   Hanson, Celine ^b   Cooper, Ellen R ^c   Read, Jennifer S ^d   Watson, Jessica ^e   Mendez, Hermann A ^f   Pitt, Jane ^g   Rich, Kenneth ^h   Smeriglio, Vincent ⁱ   Lew, Judy F ^j  

^a UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^e NEW ENGLAND RESEARCH INSTITUTES   (United States)

^f SUNY DOWNSTATE MEDICAL CENTER   (United States)

^g University of Illinois ^*  (United States)

^h UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

ⁱ NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^j NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^k UNIVERSITY OF PUERTO RICO   (Puerto Rico)

more..

Author keywords

Disease progression; Infants; Pediatric HIV; Predictors; Vertically acquired HIV

Indexed keywords

ARTICLE; CHILD; COHORT ANALYSIS; DISEASE COURSE; FEMALE; HEPATOMEGALY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFANT; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; SPLENOMEGALY; SURVIVAL; VERTICAL TRANSMISSION; VIRUS CHARACTERIZATION;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 13144276295     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199807010-00004     Document Type: Article

References (34)

1. Scott GB, Hutto C, Mastrucci RW, et al. Survival in children with perinatally infected human immunodeficiency virus type 1 infection. N Engl J Med 1989;321:1791-6.
2. Tovo PA, Martino M De, Gabiano C, et al. and the Italian Register for HIV Infection in Children. Prognostic factors and survival in children with perinatal HIV-1 infection. Lancet 1992;339:1249-53.
3. Blanche S, Tardiew M, Duliege A, et al. Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection. Am J Dis Child 1990;144:1210-15.
4. Barnhart HX, Caldwell B, Thomas P, et al. and the PSD Clinical Consortium. Natural history of HIV disease in perinatally infected children: an analysis from the Pediatric Spectrum of Disease Project. Pediatrics 1996;97:710-16.
5. Galli L, de Martino M, Tovo PA, et al. Onset of clinical signs in children with HIV-1 infection. AIDS 1995;9:455-61.
6. Italian Register for HIV Infection in Children. Features of children perinatally infected with HIV-1 surviving longer than 5 years. Lancet 1994;343:191-5.
7. Blanche S, Rouzioux C, Guilard ML, et al. and the HIV Infection in Newborns French Collaborative Study Group. A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. N Engl J Med 1989;320:1643-8.
8. European Collaborative Study. Natural history of vertically acquired human immunodeficiency virus-1 infection. Pediatrics 1994;94:815-19.
9. Italian Multicenter Study. Epidemiology, clinical features, and prognostic factors of pediatric HIV infection. Lancet 1988;2: 1043-5.
10. Duliege A, Messiah A, Blanche S, et al. Natural history of human immunodeficiency virus type 1 infection in children: prognostic value of laboratory tests on the bimodal progression of disease. Pediatr Infect Dis J 1992;11:630-5.
11. Mayaux MJ, Burgard M, Teglas JP, et al. for The French Pediatric HIV Infection Study Group. Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease. JAMA 1996;275: 606-10.
12. Blanche S, Newell M-L, Mayaux M-J, et al. and The French Pediatric HIV Infection Study Group and European Collaborative Study. Morbidity and mortality in European children vertically infected by HIV-1. J Acquir Immune Defic Syndr 1997;14:442-50.
13. Blanche S, Mayaux MJ, Rouzioux C, et al., and the French Pediatric Infection Study Group. Relation of the course of HIV infection in children to the severity of the disease in their mothers at delivery. N Engl J Med 1994;330:308-12.
14. Tovo PA, de Martino M, Gaviano C, et al. AIDS appearance in children is associated with the velocity of disease progression in their mothers. J Infect Dis 1994;170:1000-2.
15. Rossi A De, Giaquinto C, Ometto L, et al. Replication and tropism of human immunodeficiency virus type 1 as predictors of disease outcome in infants with vertically acquired infection. J Pediatr 1993;123:929-36.
16. Dickover RE, Dillon M, Gillete SG, et al. Rapid increases in load of human immunodeficiency virus correlate with early disease progression and loss of CD4 cells in vertically infected infants. J Infect Dis 1994;170:1279-84.
17. Shearer WT, Quinn TC, LaRussa P, et al. Viral load and disease progression in infants infected with HIV-1. N Engl J Med 1997; 336:1337-42.
18. Luzuriaga K, Bryson YJ, Sullivan JL, Wara DW. Proposed definitions for in-utero versus intrapartum transmission of HIV-1. N Engl J Med 1992;327:1246-7.
19. Wei X, Ghosh SK, Taylor ME, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995;373:117-22.
20. Frederick T, Mascola L, Eller A, et al. Progression of human immunodeficiency virus disease among infants and children infected perinatally with human immunodeficiency virus or through neonatal blood transfusion. Pediatr Infect Dis J 1994;13:1091-7.
21. Caldwell MB, Oxtoby MJ, Simonds RJ, et al. of the Division of HIV/AIDS of the National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC). 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR Morb Mortal Wkly Rep 1994;43(RR-12).
22. Sheon AR, Fox HE, Rich KC, et al. The Women and Infants Transmission Study (WITS) of maternal-infant HIV transmission: study, design, methods, and baseline data. J Women's Health 1996; 5:69-78.
23. Hollinger B, ed. AIDS Clinical Trials Group virology manual for HIV laboratory, version 2.1. Bethesda, MD: Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institute of Health, 1993.
24. Clavelli T, Denny TN, Paxton H, et al. Guidelines for flow cytometric immunophenotyping: a report from the National Institute of Allergy and Infectious Diseases, Division of AIDS. Cytometry 1993;14:702-15.
25. Landay AL, Brambilla D, Pitt J, et al. Interlaboratory variability of CD subset measurements by flow cytometry and its application to multicenter clinical trials. Clin Diagn Lab Immunol 1995;2:462-8.
26. Hollinger FB, Bremer JW, Myers LE, et al. and the NIH/NIAID/ DAIDS/ACTG Virology Laboratories. Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group. J Clin Microbiol 1992;30:1787-94.
27. McIntosh K, Pitt J, Brambilla D, et al. Blood culture in the first 6 months of life for the diagnosis of vertically transmitted human immunodeficiency virus infection. J Infect Dis 1994;170:996-1000.
28. Pitt J, Brambilla D, Reichelderfer P, et al. Maternal immunologic and virologic risk factors for infant human immunodeficiency virus type 1 infection: findings from the women and infants transmission study. J Infect Dis 1997;175:567-75.
29. Rodríguez EM, Mofenson LM, Chang B, et al. Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmission in the Women and Infants Transmission Study. AIDS 1996;10:273-82.
30. Miller RG Jr. Survival analysis. New York: John Wiley, 1981.
31. Hu P, Tsiatis AA. Estimating the survival distribution when ascertainment of vital status is subject to delay. Biometrika 1996;83: 371-80.
32. Centers for Disease Control. Classification system for human immunodeficiency virus (HIV) infection in children under 13 years of age. MMWR Morb Mortal Wkly Rep 1987;36:225-30,235.
33. DeGrouttola V, Fleming T, Lin DY, Coombs R. Perspective: validating surrogate markers - are we being naive? J Infect Dis 1997; 175:237-46.
34. Carpenter CJ, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1996. JAMA 1996;276:146-54.